Shareholders' Equity - Additional Information (Details) - USD ($)			1 Months Ended			12 Months Ended
	Aug. 09, 2022	Jan. 31, 2020	Jan. 31, 2023	Jan. 31, 2021	Jul. 31, 2018	Dec. 31, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Shares issued in public or private offerings, net of issuance costs, shares				17,250,000
Value of shares issued in public or private offering				$ 121,045,000		$ 121,045,000	$ 35,000,000
Shares issued in share lending agreement, shares					7,479,431
Share lending agreement, length of time for shares to be returned upon termination					5 days
Shares issued, price per share					$ 13.37
Maximum
Class of Stock [Line Items]
Sale of stock, consideration received on transaction	$ 100,000,000
Subsequent Event
Class of Stock [Line Items]
Shares issued in public or private offerings, net of issuance costs, shares			43,962,640
Value of shares issued in public or private offering			$ 73,000,000
TS Biotechnology Sale
Class of Stock [Line Items]
Shares issued in public or private offerings, net of issuance costs, shares		5,972,696
Value of shares issued in public or private offering		$ 35,000,000
Affiliated Entity | Subsequent Event
Class of Stock [Line Items]
Shares issued in public or private offerings, net of issuance costs, shares			11,517,712